101 results
Page 4 of 6
8-K
EX-99.1
3z2e7d8g1ndhmkx
10 Jan 22
Other Events
7:11am
8-K
EX-99.2
2472n27q
10 Jan 22
Other Events
7:11am
8-K
EX-99.1
rn9pywbf
27 Oct 21
Other Events
7:01am
8-K
EX-99.2
srwp skfhlr8cxobc
27 Oct 21
Other Events
7:01am
8-K
EX-99.1
gqame5tzeap96qjig
14 Oct 21
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
5:10pm
8-K
EX-99.1
9ispw0vdvwbnx1axmg
30 Sep 21
Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders
7:08am
S-3ASR
tgas03pwhumoetyssjs1
4 Aug 21
Automatic shelf registration
4:11pm
S-3ASR
EX-1.2
1pukzekhbh qy8ri
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-99.1
in605p di
13 Jul 21
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:12pm
8-K
EX-99.1
hbffnzlhs91eoxx
2 Jun 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
ofh4ayfs3f 02okzve
1 Jun 21
Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its
4:11pm
8-K
EX-99.1
p1cwm4bj6
13 Apr 21
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:08pm
424B4
v0l kq4f1x3rdeabn
5 Mar 21
Prospectus supplement with pricing info
4:07pm
DRS
eyac96vjroj9rfoao
22 Feb 21
Draft registration statement
12:00am